Xarelto Bleeding Injury $28M Verdict Tossed. What the court giveth, the court taketh away! Such is the capriciousness of the court system. The first Xarelto Bleeding Injury plaintiff’s victory against Bayer and Johnson & Johnson (J&J) over Xarelto’s bleeding risks was short lived. In the case of Lynn Hartman, Judge…
J&J successfully blocks first Xarelto Bleeding Injury trial. A Louisiana jury found for Johnson & Johnson and Bayer AG in the first Xarelto internal bleeding product liability lawsuit to go to trial. Xarelto Bleeding Injury Trial Xarelto linked to uncontrollable brain and gastrointestinal bleeding according to over 18,000 lawsuits. The federal…
According to recent revelations in the New York Times did two major pharmaceutical companies, to protect their blockbuster drug, Xarelto, intentionally mislead editors at one of the world’s most prestigious medical journals? Several thousand injured plaintiffs have filed personal injury and product liability claims against Johnson & Johnson and Bayer…
Xarelto is under fire, if you follow the allegations in the over 550 lawsuits filed to date. Xarelto is one of the newer oral anticoagulant medications that has been approved by the FDA. The federal Xarelto personal injury and product liability claims are centralized before U.S. District Judge Eldon E.…
As a Dallas Xarelto Bleeding Death attorney and Texas medical doctor, I would like to update my readers about the ongoing status of the Xarelto litigation. Most recently, a wrongful death lawsuit was filed against the makers of Xarelto; Bayer Healthcare and Johnson and Johnson’s subsidiary, Janssen. Danny Julien recently…
According to court documents and a review of the inventory of filed lawsuits against the makers of Xarelto, the litigation appears to be gathering steam and increasing in breadth and depth. In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) granted consolidated pretrial proceedings for all federal Xarelto…
The U.S. Judicial Panel on Multidistrict Litigation announced consolidation and centralization of all nationwide Xarelto lawsuits filed in federal courts before U.S. District Judge Eldon E. Fallon in the Eastern District of Louisiana. Over 50 Federal Xarelto Lawsuits Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary are exposed to…
Today, the U.S. Judicial Panel on Multidistrict Litigation (JPML) heard oral arguments to consolidate all federal Xarelto lawsuits before one judge, in one centralized U.S. District Court. It is widely anticipated that the U.S. JPML will establish centralized proceedings for coordinated discovery and a series of bellwether trials. Patients who…
Anticoagulation therapy is necessary in several serious medical conditions including a common heart rhythm abnormality, known as atrial fibrillation, deep vein thrombosis, pulmonary embolism and in certain genetic blooding clotting diseases. The medications reduce the incidence of blood clots and reduce the rate of strokes as in the case of…
Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary, the manufacturers of the novel oral anticoagulant (NOACS) Xarelto, are exposed to several Xarelto product liability personal injury lawsuits, filed nationwide. These have brought by folks who suffered a catastrophic injury or death due to uncontrollable bleeding side effects while on…